Phibro Animal Clocks 16% Jump In Q4 Sales, Plans Incremental Strategic Investments In Future
Phibro Animal Health Corp (NASDAQ: PAHC ) posted Q4 FY22 sales of $255.3 million , 16% Y|Y, beating the consensus of $246.02 million. Adjusted EPS increased 13% to $0.36, missing the consensus of $0.38. The gross margin decreased 100 basis points to 30.7%. The adjusted EBITDA … Full story available on Benzinga.com
Phibro Animal Clocks 16% Jump In Q4 Sales, Plans Incremental Strategic Investments In Future
Phibro Animal Health Corp (NASDAQ: PAHC ) posted Q4 FY22 sales of $255.3 million , 16% Y|Y, beating the consensus of $246.02 million. Adjusted EPS increased 13% to $0.36, missing the consensus of $0.38. The gross margin decreased 100 basis points to 30.7%. The adjusted EBITDA … Full story available on Benzinga.com